284 related articles for article (PubMed ID: 34716195)
21. DNMT3A R882 Mutations Predict a Poor Prognosis in AML: A Meta-Analysis From 4474 Patients.
Yuan XQ; Peng L; Zeng WJ; Jiang BY; Li GC; Chen XP
Medicine (Baltimore); 2016 May; 95(18):e3519. PubMed ID: 27149454
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of the DNMT3A R882 mutation in acute leukemia.
Huang X; Ma D; Dong W; Li P; Lu T; He N; Tian T; Liu N; DU Y; Ji C
Oncol Lett; 2013 Jul; 6(1):268-274. PubMed ID: 23946816
[TBL] [Abstract][Full Text] [Related]
23. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
24. [Effect of FLT3-ITD with DNMT3A R882 double-mutation on the prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Pei RZ; Tang XW
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):552-557. PubMed ID: 30122013
[No Abstract] [Full Text] [Related]
25. DNMT3A R882 mutations in patients with cytogenetically normal acute myeloid leukemia and myelodysplastic syndrome.
El Ghannam D; Taalab MM; Ghazy HF; Eneen AF
Blood Cells Mol Dis; 2014; 53(1-2):61-6. PubMed ID: 24512939
[TBL] [Abstract][Full Text] [Related]
26. Graphdiyne oxide nanosheets display selective anti-leukemia efficacy against DNMT3A-mutant AML cells.
Wang Q; Liu Y; Wang H; Jiang P; Qian W; You M; Han Y; Zeng X; Li J; Lu H; Jiang L; Zhu M; Li S; Huang K; Tang M; Wang X; Yan L; Xiong Z; Shi X; Bai G; Liu H; Li Y; Zhao Y; Chen C; Qian P
Nat Commun; 2022 Sep; 13(1):5657. PubMed ID: 36163326
[TBL] [Abstract][Full Text] [Related]
27. Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.
Elrhman HAEA; El-Meligui YM; Elalawi SM
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):e960-e969. PubMed ID: 34376373
[TBL] [Abstract][Full Text] [Related]
28. Quantitative detection of DNMT3A R882H mutation in acute myeloid leukemia.
Berenstein R; Blau IW; Suckert N; Baldus C; Pezzutto A; Dörken B; Blau O
J Exp Clin Cancer Res; 2015 May; 34(1):55. PubMed ID: 25994761
[TBL] [Abstract][Full Text] [Related]
29. Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia.
Jost E; Lin Q; Weidner CI; Wilop S; Hoffmann M; Walenda T; Schemionek M; Herrmann O; Zenke M; Brümmendorf TH; Koschmieder S; Wagner W
Leukemia; 2014 Jun; 28(6):1227-34. PubMed ID: 24280869
[TBL] [Abstract][Full Text] [Related]
30. DNMT3A mutations in acute myeloid leukemia.
Ley TJ; Ding L; Walter MJ; McLellan MD; Lamprecht T; Larson DE; Kandoth C; Payton JE; Baty J; Welch J; Harris CC; Lichti CF; Townsend RR; Fulton RS; Dooling DJ; Koboldt DC; Schmidt H; Zhang Q; Osborne JR; Lin L; O'Laughlin M; McMichael JF; Delehaunty KD; McGrath SD; Fulton LA; Magrini VJ; Vickery TL; Hundal J; Cook LL; Conyers JJ; Swift GW; Reed JP; Alldredge PA; Wylie T; Walker J; Kalicki J; Watson MA; Heath S; Shannon WD; Varghese N; Nagarajan R; Westervelt P; Tomasson MH; Link DC; Graubert TA; DiPersio JF; Mardis ER; Wilson RK
N Engl J Med; 2010 Dec; 363(25):2424-33. PubMed ID: 21067377
[TBL] [Abstract][Full Text] [Related]
31. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.
Mancini M; Hasan SK; Ottone T; Lavorgna S; Ciardi C; Angelini DF; Agostini F; Venditti A; Lo-Coco F
J Mol Diagn; 2015 Mar; 17(2):179-84. PubMed ID: 25554589
[TBL] [Abstract][Full Text] [Related]
32. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients.
El Gammal MM; Ebid GT; Madney YM; Abo-Elazm OM; Kelany AK; Torra OS; Radich JP
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e281-e290. PubMed ID: 30926392
[TBL] [Abstract][Full Text] [Related]
33. DNMT3A R882 mutation is associated with elevated expression of MAFB and M4/M5 immunophenotype of acute myeloid leukemia blasts.
Yang L; Liu Y; Zhu L; Xiao M
Leuk Lymphoma; 2015; 56(10):2914-22. PubMed ID: 25721756
[TBL] [Abstract][Full Text] [Related]
34. Systematic Profiling of
Huang YH; Chen CW; Sundaramurthy V; Słabicki M; Hao D; Watson CJ; Tovy A; Reyes JM; Dakhova O; Crovetti BR; Galonska C; Lee M; Brunetti L; Zhou Y; Tatton-Brown K; Huang Y; Cheng X; Meissner A; Valk PJM; Van Maldergem L; Sanders MA; Blundell JR; Li W; Ebert BL; Goodell MA
Cancer Discov; 2022 Jan; 12(1):220-235. PubMed ID: 34429321
[TBL] [Abstract][Full Text] [Related]
35. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
[TBL] [Abstract][Full Text] [Related]
36. Cooperation of Dnmt3a R878H with Nras G12D promotes leukemogenesis in knock-in mice: a pilot study.
Shi X; Yang Y; Shang S; Wu S; Zhang W; Peng L; Huang T; Zhang R; Ren R; Mi J; Wang Y
BMC Cancer; 2019 Nov; 19(1):1072. PubMed ID: 31703632
[TBL] [Abstract][Full Text] [Related]
37. Clinical Features and MicroRNA Expression Patterns Between AML Patients With DNMT3A R882 and Frameshift Mutations.
Yang L; Shen K; Zhang M; Zhang W; Cai H; Lin L; Long X; Xing S; Tang Y; Xiong J; Wang J; Li D; Zhou J; Xiao M
Front Oncol; 2019; 9():1133. PubMed ID: 31709191
[No Abstract] [Full Text] [Related]
38. Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia.
Ibrahem L; Mahfouz R; Elhelw L; Abdsalam EM; Soliman R
Blood Cells Mol Dis; 2015 Jan; 54(1):84-9. PubMed ID: 25172541
[TBL] [Abstract][Full Text] [Related]
39. First-in-Class Allosteric Inhibitors of DNMT3A Disrupt Protein-Protein Interactions and Induce Acute Myeloid Leukemia Cell Differentiation.
Sandoval JE; Ramabadran R; Stillson N; Sarah L; Fujimori DG; Goodell MA; Reich N
J Med Chem; 2022 Aug; 65(15):10554-10566. PubMed ID: 35866897
[TBL] [Abstract][Full Text] [Related]
40. Persistence of DNMT3A mutations at long-term remission in adult patients with AML.
Pløen GG; Nederby L; Guldberg P; Hansen M; Ebbesen LH; Jensen UB; Hokland P; Aggerholm A
Br J Haematol; 2014 Nov; 167(4):478-86. PubMed ID: 25371149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
